Personalized Medicine Market Set To Grow From $469.11 Billion In 2026 To $733.26 Billion By 2030 At A CAGR Of 11.8%
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Personalized Medicine Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The personalized medicine market has experienced swift expansion in recent years. Projections indicate an increase from $422.9 billion in 2025 to $469.11 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.9%. This historical growth has been driven by factors such as the growing incidence of chronic conditions, progress in genetic sequencing technologies, higher spending on healthcare, heightened awareness surrounding personalized treatment approaches, and the early integration of digital health tools.
Over the next several years, the personalized medicine sector is expected to experience swift growth, with its market size projected to climb to $733.27 billion by 2030—representing a compound annual growth rate (CAGR) of 11.8%. A range of factors are fueling this expansion during the forecast period, including the integration of artificial intelligence into diagnostics and therapeutics, an increase in gene and cell therapy product availability, rising demand for remote patient monitoring, the development of precision nutrition solutions, and growing adoption of companion diagnostics. Among the notable trends shaping this period are personalized genetic profiling, targeted drug development, patient-centric models of care, remote health monitoring systems, and preventive therapies based on lifestyle.
Download A Free Sample Report For Comprehensive Market Insights:
Personalized Medicine Market Industry Drivers: What Is Driving Revenue Growth?
The increasing number of obese individuals is anticipated to drive the expansion of the personalized medicine market in the coming years. Obesity is defined as the abnormal or excessive buildup of fat that can negatively affect a person’s health. Personalized medicine is utilized to target the specific genetic and molecular factors that contribute to obesity, enabling customized and effective treatments for each patient. For example, in December 2024, the Office for Health Improvement and Disparities, a UK-based government agency, reported that between 2022 and 2023, the rate of women recorded as obese during early pregnancy stood at 25.4%, which then rose slightly to 26.2% from 2023 to 2024. As a result, the rising prevalence of obesity is fueling growth in the personalized medicine market.
Personalized Medicine Market Segment Analysis And Revenue Opportunities
The personalized medicine market covered in this report is segmented –
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users
Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs
Personalized Medicine Market Growth Trends: What Is Influencing The Future Outlook?
Key players in the personalized medicine sector are prioritizing the creation of advanced technologies, including platforms driven by artificial intelligence (AI), to improve diagnostic precision, refine treatment customization, and boost the effectiveness of clinical trials. These AI-based systems rely on comprehensive data analysis to deliver practical insights regarding disease development, patient reactions, and treatment results. A case in point is April 2023, when OM1, a US healthcare firm that employs real-world data alongside AI, secured a patent for an AI-powered platform aimed at advancing personalized medicine. This platform delivers tailored healthcare suggestions, assists healthcare professionals in making well-informed choices, and accelerates clinical trials by precisely pinpointing suitable participants. The incorporation of AI-driven analytics into medical practices fosters the progress of personalized medicine and enhances its overall impact.
Personalized Medicine Market Leading Players Shaping Industry Direction
Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.
Access The Complete Personalized Medicine Market Report:
Personalized Medicine Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
